532384 Stock Overview
Manufactures and sells active pharmaceutical ingredients and intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
Tyche Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹182.95 |
| 52 Week High | ₹230.00 |
| 52 Week Low | ₹148.60 |
| Beta | 0.69 |
| 11 Month Change | 3.83% |
| 3 Month Change | -16.75% |
| 1 Year Change | 0.41% |
| 33 Year Change | -16.95% |
| 5 Year Change | 310.20% |
| Change since IPO | 3,559.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532384 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 4.4% | 2.2% | -1.0% |
| 1Y | 0.4% | 46.7% | 43.6% |
Return vs Industry: 532384 underperformed the Indian Pharmaceuticals industry which returned 46.7% over the past year.
Return vs Market: 532384 underperformed the Indian Market which returned 43.6% over the past year.
Price Volatility
| 532384 volatility | |
|---|---|
| 532384 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.7% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532384 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532384's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 166 | Ganesh Gokaraju | www.tycheindustries.net |
Tyche Industries Limited manufactures and sells active pharmaceutical ingredients and intermediates in India. It also provides chiral intermediates and nutraceuticals; and contract drug substance and analytical development, as well as contract manufacturing services. The company primarily exports its products to the United States and Europe.
Tyche Industries Limited Fundamentals Summary
| 532384 fundamental statistics | |
|---|---|
| Market cap | ₹1.87b |
| Earnings (TTM) | ₹122.43m |
| Revenue (TTM) | ₹695.10m |
15.3x
P/E Ratio2.7x
P/S RatioIs 532384 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532384 income statement (TTM) | |
|---|---|
| Revenue | ₹695.10m |
| Cost of Revenue | ₹291.81m |
| Gross Profit | ₹403.29m |
| Other Expenses | ₹280.87m |
| Earnings | ₹122.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 11.95 |
| Gross Margin | 58.02% |
| Net Profit Margin | 17.61% |
| Debt/Equity Ratio | 0% |
How did 532384 perform over the long term?
See historical performance and comparison